Yuan Zhi
Stock Analyst at B. Riley Securities
(2.81)
# 1,698
Out of 5,154 analysts
32
Total ratings
41.94%
Success rate
0.8%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RADX Radiopharm Theranostics | Reiterates: Buy | $13 → $16 | $4.99 | +220.64% | 3 | Dec 16, 2025 | |
| RDNT RadNet | Maintains: Buy | $71 → $87 | $60.68 | +43.38% | 2 | Dec 1, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $14 | $16.95 | -17.40% | 3 | Nov 18, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $11 | $4.97 | +121.33% | 4 | Nov 18, 2025 | |
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $20.54 | +7.11% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $2.78 | +115.83% | 1 | Jul 16, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.07 | -6.54% | 2 | May 15, 2025 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $2.96 | +508.11% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $8.09 | +85.41% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.80 | +275.94% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $24.30 | +225.10% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.20 | +1,233.33% | 4 | Dec 11, 2023 |
Radiopharm Theranostics
Dec 16, 2025
Reiterates: Buy
Price Target: $13 → $16
Current: $4.99
Upside: +220.64%
RadNet
Dec 1, 2025
Maintains: Buy
Price Target: $71 → $87
Current: $60.68
Upside: +43.38%
Tango Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $16.95
Upside: -17.40%
Perspective Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $4.97
Upside: +121.33%
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $20.54
Upside: +7.11%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $2.78
Upside: +115.83%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.07
Upside: -6.54%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $2.96
Upside: +508.11%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $8.09
Upside: +85.41%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.80
Upside: +275.94%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $24.30
Upside: +225.10%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.20
Upside: +1,233.33%